or Try an Advanced Search...

    Technical Analysis for XFOR - X4 Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.52 3.76% 0.02
    XFOR closed up 3.76 percent on Friday, November 1, 2024, on approximately normal volume.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical XFOR trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze Started Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    20 DMA Resistance Bearish 3.76%
    Gapped Up Strength 3.76%
    20 DMA Resistance Bearish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Older End-of-Day Signals for XFOR ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 17 hours ago
    Possible Inside Day about 17 hours ago
    Rose Above 20 DMA about 20 hours ago
    60 Minute Opening Range Breakout about 20 hours ago
    Up 5% about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    XFOR Chart by TradingView
    Basic chart:

    Profile

    X4 Pharmaceuticals, Inc., formerly Arsanis, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare diseases including primary immunodeficiencies and cancer. The Company’s oral small molecule drug candidates antagonize the CXCR4 pathway, which plays a central role in immune surveillance. Its product candidates include X4P-001, X4P-002 and X4P-003.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Rare Diseases Small Molecule Treatment Of Rare Diseases

    Is XFOR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 24 X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024
    Oct 1 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Sep 18 X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a favorite amongst institutional investors who own 51%
    Aug 28 X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
    Aug 13 XFOR: First Commercial Sales of XOLREMDI™…
    Aug 10 X4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call Transcript
    Aug 8 X4 Pharmaceuticals: Q2 Earnings Snapshot
    Aug 8 X4 Pharmaceuticals GAAP EPS of $0.45 beats by $0.46
    Aug 8 X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
    Aug 7 X4 Pharmaceuticals Q2 2024 Earnings Preview
    See more XFOR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.6
    52 Week Low 0.4722
    Average Volume 1,012,733
    200-Day Moving Average 0.86
    50-Day Moving Average 0.62
    20-Day Moving Average 0.52
    10-Day Moving Average 0.50
    Average True Range 0.04
    RSI (14) 43.82
    ADX 30.86
    +DI 16.14
    -DI 20.84
    Chandelier Exit (Long, 3 ATRs) 0.53
    Chandelier Exit (Short, 3 ATRs) 0.59
    Upper Bollinger Bands 0.56
    Lower Bollinger Band 0.47
    Percent B (%b) 0.54
    BandWidth 16.10
    MACD Line -0.03
    MACD Signal Line -0.04
    MACD Histogram 0.0063
    Fundamentals Value
    Market Cap 86.82 Million
    Num Shares 167 Million
    EPS -0.68
    Price-to-Earnings (P/E) Ratio -0.76
    Price-to-Sales 53.87
    Price-to-Book 2.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.58
    Resistance 3 (R3) 0.58 0.56 0.57
    Resistance 2 (R2) 0.56 0.54 0.56 0.56
    Resistance 1 (R1) 0.54 0.53 0.55 0.54 0.56
    Pivot Point 0.52 0.52 0.52 0.52 0.52
    Support 1 (S1) 0.50 0.51 0.51 0.50 0.48
    Support 2 (S2) 0.48 0.50 0.48 0.47
    Support 3 (S3) 0.46 0.48 0.47
    Support 4 (S4) 0.46